ISSCR: Copenhagen International Symposium, “PSC-Derived Cell Therapies: Clinical Advances, NextGen Technologies, and the Path to Success”

Copenhagen, Denmark

ISSCR Copenhagen International SymposiumProgram Description: Pluripotent stem cell-derived cell therapies are accelerating rapidly into clinical trials. The ISSCR, in partnership with Novo Nordisk, is pleased to invite you to Copenhagen, Denmark in October 2024 for an event that will gather pioneers at the forefront of ESC and iPSC-derived cell therapies. Here, world-renowned scientists and innovators will share the latest updates on ongoing clinical trials, as well as groundbreaking platforms and technologies that will revolutionize the next generation of cell therapies for devastating and intractable diseases.

Register Now:

Add to Calendar:  Google Calendar    ICS

Call for Abstracts

Closes 31 July 2024 at 23:59 EDT (USA)

Submit an Abstract:

The International Society for Stem Cell Research (ISSCR) invites you to submit an abstract and take advantage of the opportunity to be offered an oral or a poster presentation at the Copenhagen International Symposium, held 2 – 4  October 2024. Abstract-selected Oral and Poster presenters MUST attend the meeting in-person.

  • There is a non-refundable $45.00 USD abstract submission fee for each abstract submitted
  • Presentation notifications will be sent by Thursday, 15 August 2024
  • Please contact with any abstract related questions
  • Please contact with any registration questions
    • To register for the meeting, please click HERE

All submitted abstracts are evaluated by the Organizing Committee to ensure that they meet submission standards, Abstracts that do not meet these criteria may be rejected. Submitted abstracts must:

To begin your submission, please click ‘Login’ to log into your existing ISSCR account or to create an ISSCR account.


  • Presented abstracts will be included in the ISSCR 2024 Copenhagen International Symposium Program eBook.
  • Please add to your contacts list to ensure you receive all communications. The email address used to log into the submission site will receive updates and information about your submission.


View event on ISSCR: